Jubilant Life Sciences’ wholly-owned subsidiary -- Jubilant Pharma (JPL) has received approval to launch an offering of unsecured bonds outside India. The Notes are proposed to be issued to institutional investors outside India and listed and quoted on the Official List of the Singapore Exchange Securities Trading.
JPL proposes to undertake meetings with one or more potential international institutional investors located in different jurisdictions. The Board of Directors of Jubilant Pharma at its meeting held on February 25, 2019 has approved the same.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
